China’s Ping An buys stake in Japanese herbal drugs firm

The Chinese insurer and Japan’s Tsumura will jointly make and sell the latter's traditional medicine products in China.

Alison Tudor-Ackroyd

September 22, 2017

Ping An Insurance is buying a 10% stake in Tsumura, which makes and sells Japanese herbal medicine, known as kampo drugs.

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].